Search Results Search Sort by RelevanceMost Recent Personal Narrative Apr 2016 An Open Letter to Medical Students: Down Syndrome, Paradox, and Medicine George Estreich Physicians must resist judging the quality of life of their patients with Down syndrome and learn to listen and see them as individual personalities. AMA J Ethics. 2016;18(4):438-441. doi: 10.1001/journalofethics.2016.18.4.mnar1-1604. Case and Commentary Apr 2019 Should a Psychiatrist Prescribe a Nanodrug to Help Parents Monitor a Teen’s Adherence? Constance E. George, MD, MA Ethical stakes include a psychiatrist’s care management responsibilities and burdens borne by family members over the course of the patient’s care. AMA J Ethics. 2019;21(4):E317-323. doi: 10.1001/amajethics.2019.317. Case and Commentary Mar 2005 Drug Testing in Adolescents Todd S. Varness, MD, MPH and Norman Fost, MD, MPH Virtual Mentor. 2005;7(3):208-212. doi: 10.1001/virtualmentor.2005.7.3.ccas1-0503. Case and Commentary Mar 2005 An Adolescent with an Eating Disorder Garry Sigman, MD Virtual Mentor. 2005;7(3):213-217. doi: 10.1001/virtualmentor.2005.7.3.ccas2-0503. Medicine and Society Oct 2006 Talking with Families about Severely Disabled Children Arthur F. Kohrman, MD Virtual Mentor. 2006;8(10):685-688. doi: 10.1001/virtualmentor.2006.8.10.msoc1-0610. Case and Commentary Jul 2004 Limits of Youth Sports Training, Commentary 1 David T. Bernhardt, MD Virtual Mentor. 2004;6(7):293-297. doi: 10.1001/virtualmentor.2004.6.7.ccas1-0407. Case and Commentary Jul 2004 Limits of Youth Sports Training, Commentary 2 Lyle J. Micheli, MD Virtual Mentor. 2004;6(7):295-297. doi: 10.1001/virtualmentor.2004.6.7.ccas1-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Personal Narrative Apr 2016 An Open Letter to Medical Students: Down Syndrome, Paradox, and Medicine George Estreich Physicians must resist judging the quality of life of their patients with Down syndrome and learn to listen and see them as individual personalities. AMA J Ethics. 2016;18(4):438-441. doi: 10.1001/journalofethics.2016.18.4.mnar1-1604.
Case and Commentary Apr 2019 Should a Psychiatrist Prescribe a Nanodrug to Help Parents Monitor a Teen’s Adherence? Constance E. George, MD, MA Ethical stakes include a psychiatrist’s care management responsibilities and burdens borne by family members over the course of the patient’s care. AMA J Ethics. 2019;21(4):E317-323. doi: 10.1001/amajethics.2019.317.
Case and Commentary Mar 2005 Drug Testing in Adolescents Todd S. Varness, MD, MPH and Norman Fost, MD, MPH Virtual Mentor. 2005;7(3):208-212. doi: 10.1001/virtualmentor.2005.7.3.ccas1-0503.
Case and Commentary Mar 2005 An Adolescent with an Eating Disorder Garry Sigman, MD Virtual Mentor. 2005;7(3):213-217. doi: 10.1001/virtualmentor.2005.7.3.ccas2-0503.
Medicine and Society Oct 2006 Talking with Families about Severely Disabled Children Arthur F. Kohrman, MD Virtual Mentor. 2006;8(10):685-688. doi: 10.1001/virtualmentor.2006.8.10.msoc1-0610.
Case and Commentary Jul 2004 Limits of Youth Sports Training, Commentary 1 David T. Bernhardt, MD Virtual Mentor. 2004;6(7):293-297. doi: 10.1001/virtualmentor.2004.6.7.ccas1-0407.
Case and Commentary Jul 2004 Limits of Youth Sports Training, Commentary 2 Lyle J. Micheli, MD Virtual Mentor. 2004;6(7):295-297. doi: 10.1001/virtualmentor.2004.6.7.ccas1-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.